Spatial transcriptomics is one of the most exciting disciplines in digital pathology. To support more collaborative study and advance our collective understanding of tissue, a centralized platform for images, metadata, and analysis results is essential.

A recent “Pathology at Life Speed” session brought together Proscia CTO Coleman Stavish and Andrew Fisher, Principal Scientist in Translational Bioinformatics at Bristol Myers Squibb, to discuss how the latest technology is accelerating spatial transcriptomics research. Video of the session contains a number of worthwhile insights:

• Spatial transcriptomics adds granularity to bulk sequencing of tumor specimens and raises the signal-to-noise ratio in sequencing.
• The technology unlocks the potential of each image to discover where specifically within a tumor genes are being expressed.
• The ability to house images, data, and results together in a common organizational ecosystem helps establish best practices for leveraging that information.

This video is invaluable for life sciences researchers and pathologists. Watch it now.

About Proscia: Proscia’s mission is to transform cancer research and diagnosis with intelligent software that changes the way the world practices pathology. The company’s Concentriq® for Research digital pathology platform unifies multi-site teams, data, and applications to improve collaboration and unlock groundbreaking insights.